Thomas Braxton King, President & CEO at Alexza Pharmaceuticals Inc. (ALXA), bought 40,000 shares at $4.48 ($179K) on 2013-07-24, disclosed to the SEC on 2013-07-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.48 | 25,000 | $112K | 62.4% |
| 2 | $4.50 | 12,580 | $57K | 31.5% |
| 3 | $4.49 | 2,420 | $11K | 6.1% |
| Total | $4.49 avg | 40,000 | $179K | 100% |
| Filing → |
| ALXA | SELL | 2012-06-08 | $22K | — | Filing → |
| ALXA | SELL | 2009-12-21 | $100K | — | Filing → |
| ALXA | SELL | 2009-12-18 | $100K | — | Filing → |